8-Hydroxy-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one

Catalog No. :
ACXEQH052
CAS No. :
91021-93-1
Molecular Formula :
C13H17N5O5
Molecular Weight :
323.31

IUPAC Name:8-hydroxy-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one

8-Hydroxy-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Hydroxy-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one
IUPAC Name8-hydroxy-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5,6,7,8-tetrahydropyrimido[1,2-a]purin-10(3H)-one
Molecular FormulaC13H17N5O5
Molecular Weight323.31
SMILESO=C1N2C(NC3=C1N=CN3[C@@H]4O[C@H](CO)[C@@H](O)C4)=NCCC2O
InChI KeyINAGNQRTDPXONR-QRDCSKFFSA-N
Synonym3-(2-Deoxy-β-D-erythro-pentofuranosyl)-4,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-a]purin-10(3H)-one (~90%);Pyrimido[1,2-a]purin-10(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-4,6,7,8-tetrahydro-8-hydroxy-;γ-Hydroxy-1,N-propano-2′-deoxyguanosine;3-(2-Deoxy-Beta-D-erythro-pentofuranosyl)-4,6,7,8-tetrahydro-8-hydroxypyrimido[1,2-a]purin-10(3H)-one (~90%)
CAS No.91021-93-1

Synthetic Route by SureRoute

1. ACXEQH052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEQH052 route product structure diagram
    ACXEQH05291021-93-1
Inquiry

2. ACXEQH052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEQH052 route product structure diagram
    ACXEQH05291021-93-1
Inquiry

Comments (0)